Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H-P Hartung

Showing results (11-20 of 426) with videos related to

Pageof 43
Sort By:
Lancet (London, England)|September 29, 2000
NICE and drugs for multiple sclerosis. National Institute of Clinical ExcellenceH P Hartung
Journal of Neuroimmunology|January 1, 1991
Suppression of actively induced and passively transferred experimental allergic neuritis by cyclosporin AH P Hartung
Annals of Neurology|June 1, 1993
Immune-mediated demyelinationH P Hartung
Journal of Neurology, Neurosurgery, and Psychiatry|January 11, 2002
Despair of repairM Stangel, H-P Hartung
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 28, 2001
In search of a disease marker: the cytokine profile of primary progressive multiple sclerosisO Neuhaus, H P Hartung
Journal of Neural Transmission. Supplementum|January 1, 1997
Pathogenesis of immune-mediated demyelination in the CNSH P Hartung, P Rieckmann
Current Opinion in Neurology|June 1, 1996
The immunopathogenesis of multiple sclerosis and Guillain-Barré syndromeG Giovannoni, H P Hartung
Der Nervenarzt|June 1, 1996
[Course of illness and prognosis of multiple sclerosis. 1: The natural illness course]P Flachenecker, H P Hartung
Agents and Actions|August 1, 1983
Complement components in relation to macrophage functionH P Hartung, U Hadding
Springer Seminars in Immunopathology|January 1, 1983
Synthesis of complement by macrophages and modulation of their functions through complement activationH P Hartung, U Hadding
Pageof 43

Showing results (11-20 of 426) with videos related to

Sort By:
Pageof 43
Lancet (London, England)|September 29, 2000
NICE and drugs for multiple sclerosis. National Institute of Clinical ExcellenceH P Hartung
Journal of Neuroimmunology|January 1, 1991
Suppression of actively induced and passively transferred experimental allergic neuritis by cyclosporin AH P Hartung
Annals of Neurology|June 1, 1993
Immune-mediated demyelinationH P Hartung
Journal of Neurology, Neurosurgery, and Psychiatry|January 11, 2002
Despair of repairM Stangel, H-P Hartung
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 28, 2001
In search of a disease marker: the cytokine profile of primary progressive multiple sclerosisO Neuhaus, H P Hartung
Journal of Neural Transmission. Supplementum|January 1, 1997
Pathogenesis of immune-mediated demyelination in the CNSH P Hartung, P Rieckmann
Current Opinion in Neurology|June 1, 1996
The immunopathogenesis of multiple sclerosis and Guillain-Barré syndromeG Giovannoni, H P Hartung
Der Nervenarzt|June 1, 1996
[Course of illness and prognosis of multiple sclerosis. 1: The natural illness course]P Flachenecker, H P Hartung
Agents and Actions|August 1, 1983
Complement components in relation to macrophage functionH P Hartung, U Hadding
Springer Seminars in Immunopathology|January 1, 1983
Synthesis of complement by macrophages and modulation of their functions through complement activationH P Hartung, U Hadding
Pageof 43